CJC-1295 3mg / Ipamorelin 3mg / GHRP-2 3mg Blend

Research Overview

Growth hormone release from pituitary somatotrophs is governed by two complementary axes: the GHRH receptor, which drives synthesis and pulsatile release, and the growth hormone secretagogue receptor (GHS-R1a, the ghrelin receptor), which amplifies release and suppresses somatostatin tone. CJC-1295 is a modified GHRH analog engaging the first pathway; Ipamorelin and GHRP-2 are secretagogues engaging the second, with Ipamorelin noted for high selectivity and GHRP-2 for greater potency alongside reported prolactin and cortisol effects at higher exposures. Combining all three lets researchers examine whether convergent stimulation produces synergistic rather than additive somatotroph output. Laboratory applications include pituitary cell culture, GH pulsatility profiling, receptor cross-talk studies, and comparative pharmacology against single-agent controls.

Common Research Areas

• Growth hormone axis research
• GHRH receptor pharmacology
• Ghrelin receptor signaling
• Pituitary somatotroph studies
• Combination pathway research
• Endocrine pulsatility profiling

Key Features

• Presentation: Lyophilized vial (blend) at CJC-1295 3 mg / Ipamorelin 3 mg / GHRP-2 3 mg
• Category: Growth Hormone & Performance — wholesale supply only
• Minimum order quantity: 10 units per SKU
• Applied in growth hormone axis research and ghrh receptor pharmacology
• Cold-chain handling: store at 2–8°C, protected from light
• Research Use Only — not for human or animal consumption

Product Information

Category

Growth Hormone & Performance

Format

Lyophilized vial (blend)

Strength

CJC-1295 3 mg / Ipamorelin 3 mg / GHRP-2 3 mg

Minimum Order Quantity

10 units

Wholesale Availability

Wholesale only

Why Researchers Choose This Product

This co-formulation gives laboratories a fixed three-component ratio for studying convergent somatotroph stimulation. Preparing such a blend manually compounds handling error across three peptides; a single vial holds the ratio constant across every replicate and study arm.

Storage

Store lyophilized vials refrigerated at 2–8°C. Protect from heat and light. Reconstituted material should be kept refrigerated and handled under aseptic laboratory conditions. For laboratory research use only.

Frequently Asked Questions

What is CJC-1295 3mg / Ipamorelin 3mg / GHRP-2 3mg Blend studied for?

This triple blend combines CJC-1295 with two growth hormone secretagogues, Ipamorelin and GHRP-2. It supports research into dual-pathway stimulation of somatotroph signaling, pairing GHRH receptor activity with ghrelin receptor agonism. Fixed-ratio co-formulation across three peptides removes compounding handling error, allowing convergent somatotroph stimulation to be tested against single-agent controls with confidence.

What research applications does CJC-1295 3mg / Ipamorelin 3mg / GHRP-2 3mg Blend support?

Reported laboratory applications span growth hormone axis research, ghrh receptor pharmacology, ghrelin receptor signaling, pituitary somatotroph studies, combination pathway research, and endocrine pulsatility profiling. This co-formulation gives laboratories a fixed three-component ratio for studying convergent somatotroph stimulation. Preparing such a blend manually compounds handling error across three peptides; a single vial holds the ratio constant across every replicate and study arm.

What format, strength, and minimum order apply?

CJC-1295 3mg / Ipamorelin 3mg / GHRP-2 3mg Blend is supplied as lyophilized vial (blend) at CJC-1295 3 mg / Ipamorelin 3 mg / GHRP-2 3 mg. The minimum order quantity is 10 units per SKU, and it is available to wholesale buyers only — laboratories, research organizations, distributors, and qualified commercial accounts.

How should this product be stored and handled?

Store lyophilized vials refrigerated at 2–8°C. Protect from heat and light. Reconstituted material should be kept refrigerated and handled under aseptic laboratory conditions. For laboratory research use only.

Is this product suitable for human or animal use?

No. This product is supplied strictly for laboratory and scientific research by qualified professionals. It is not for human or animal consumption, is not intended for human or veterinary use, and is not approved to diagnose, treat, cure, or prevent any disease.

This product is intended exclusively for laboratory research and analytical purposes. NOT FOR HUMAN CONSUMPTION. Not intended to diagnose, treat, cure, or prevent any disease.